Royalty Pharma
RPRX
#602
Rank
S$50.83 B
Marketcap
S$88.41
Share price
1.08%
Change (1 day)
74.96%
Change (1 year)

EPS for Royalty Pharma (RPRX)

EPS in 2026 (TTM): S$1.96

According to Royalty Pharma's latest financial reports the company's current EPS (TTM) is S$1.98. In 2025 the company made an earnings per share (EPS) of S$2.31 a decrease over its 2024 EPS that were of S$2.49.

EPS history for Royalty Pharma from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$1.96-15.09%
2025S$2.31-7.1%
2024S$2.49
2020S$1.96

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Abbott Laboratories
ABT
S$3.49 76.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$39.90 1,920.04%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
S$6.69 238.73%๐Ÿ‡บ๐Ÿ‡ธ USA